At Lisata Therapeutics (“Lisata” or the “Company”), we are dedicated to the development of innovative therapies based on clear differentiation and rigorous data applied in areas of high unmet medical need. We pledge to use our experience and knowledge to advance science, research, and development. Lisata encourages awareness of and participation in its clinical trials and believes that participating in clinical trials is the best way for patients to access investigational drugs prior to regulatory approval.

Currently, Lisata does not make its unapproved drugs available on an expanded access basis. Lisata does, however, encourage interested individuals to contact the Company regarding potential participation in its clinical trials.

If you have any questions regarding potential participation in Lisata’s clinical trials or about this expanded access policy, please contact us.

As authorized by the 21st Century Cures Act, Lisata may revise this policy at any time.